Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 9305 - 9312 of 12007 results

Jury Hits Employer With $2.2 Million Verdict For GINA Violations in Workplace Defecator Case

June 29, 2015| Blog| Viewpoint

DOJ Sues Four Michigan Hospitals for Secret Agreements Not to Compete

June 29, 2015| Alert| Viewpoint

E2’s “Revitalizing America's Middle Class in a Clean Energy Economy” Featuring Senator Elizabeth Warren

June 29, 2015| Blog| Viewpoint

Crowdfunding and IP in Health and Biotech Start-ups (Part 3): Potential Dangers

June 29, 2015| Blog| Viewpoint

The IRS's Proposed ABLE Regulations: Obstacles to Launching State Programs, and Potential Solutions

June 29, 2015| Blog| Viewpoint

FDA Reports Results of Annual Crack Down on Illegal Internet Pharmacies

June 26, 2015| Blog| Viewpoint

House Focuses on Environmental Regulations as Recess Looms

June 25, 2015| Blog| Viewpoint

SEC charges "Which EB-5" owners with securities law violations

June 25, 2015| Blog| Viewpoint

News & Press Releases

Mintz Advises ArriVent BioPharma on $75 Million Underwritten Public Offering

July 08, 2025

Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“

Mintz Advises S2G Investments on $40M Series B Financing of Sojo Industries

July 07, 2025

Mintz represented S2G Investments, a multi-stage investment firm focused on venture and growth-stage businesses across food & agriculture, oceans and energy, in its $40 million Series B financing of Sojo Industries, an industrial automation company that utilizes robotics, mobility, and software to deliver packaging and assembly solutions to the food and beverage industry.

Mintz Advises Syntis Bio on $33 Million Series A Financing

July 02, 2025

Mintz advised Syntis Bio, a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes, and rare diseases, on a $33 million oversubscribed Series A financing.

View all News and Press Releases